<DOC>
	<DOCNO>NCT02088918</DOCNO>
	<brief_summary>A Randomized , Open-label , Single-dose , 2-Sequence , 2-Period , Crossover Study Assess Safety Pharmacokinetics Nateglinide/Metformin HCl Combined Tablet Compared Nateglinide 120 mg Tablet Metformin HCl 500 mg Tablet Fasting Conditions Healthy Male Subjects</brief_summary>
	<brief_title>A Open-label , Single-dose , 2-Sequence , 2-Period , Crossover Study Assess Safety Pharmacokinetics Nateglinide/Metformin HCl Combined Tablet Compared With Nateglinide 120 mg Tablet Metformin HCl 500 mg Tablet Under Fasting Conditions Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 20 40 Signed inform consent Has history hypersensitivity IP ingredient Hypertension hyportension</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>